Angiogenic peptides in prostatic disease

BJU International

Volumn 84, Issue 9, 1999, Pages 1081-1083

  Walsh, K ^a,b   Sherwood, R A ^a   Dew, T K ^a   Mulvin, D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Malignancy; Prostate cancer; Tumour marker; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; PROSTATE SPECIFIC ANTIGEN; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SERUM;

AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032715316     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00363.x     Document Type: Article

References (17)

1. 1 Stamey TA, Yang N, Hay A et al. Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Eng J Med 1987; 317: 909-16
2. 2 Chung LW, Cunha GR. Stromal epithelial interactions. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate 1983; 4: 503-11
3. 3 Rodeck U, Herlyn M. Growth factors in melanoma. Cancer Met Rev 1991; 10: 89-101
4. 4 Morrison RS, Giordano S, Yamaguchi F et al. Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 1993; 34: 502-9
5. 5 Weidner N, Semple JP, Welch W et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Eng J Med 1991; 324: 2-8
6. 6 Gimbrone MA, Leapman S, Cotran R et al. Tumour dormancy in vivo by prevention of neovascularity. J Exp Med 1972; 136: 261-76
7. 7 Knighton D, Ausprunk D, Tapper D et al. Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 1977; 35: 347-56
8. 8 Hori A, Sasada R, Matsutani E et al. Suppression of solid tumour growth by immunoneutralising monoclonal antibody against human basic fibroblast growth factor, Cancer Res 1991; 55: 510-3
9. 9 Yang E, Moses HL. Transforming growth factor (1 induced changes in cell migration, proliferation and angiogenesis in chicken chorioallantoic membrane. J Cell Biology 1990; 111: 731-41
10. 10 Fujimoto K, Ichimori Y, Kakizoe T et al. Increased serum levels of basic libroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 1991; 180: 386-92
11. 11 Dirix LY, Vermeulen PB, Pawinski A et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothclial growth factor in sera of cancer patients. Br J Cancer 1997; 76: 238-43
12. 12 Chybowski FM, Keller JL, Bergstradh EJ et al. Predicting radionuclide bone scan findings in patients with newly diagnosed untreated prostate cancer. PSA is superior to all other parameters. J Urol 1991; 145: 313-8
13. 13 Fidler IJ, Ellis ML. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-8
14. 14 Plate KH, Brier G, Weich HA et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-55
15. 15 Boocock CA, Charnock Jones DS, Sharkey AM et al. Expression of vascular endothelial growth and its receptors III and KDR in ovarian carcinoma. J Natl Canc Inst 1995; 87: 506-16.
16. 16 Meyer G, Yu E, Siegal JA et al. Serum bFGF in men with and without prostate carcinoma. Cancer 1995; 76: 2304-11
17. 17 O'Brien TS, Smith K. Cranston D et al. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol 1995; 76: 311-4